Evidence map›Paper›PMID 33789703›Full record

Observational studyVirology journal2021

Scores based on neutrophil percentage and lactate dehydrogenase with or without oxygen saturation predict hospital mortality risk in severe COVID-19 patients.

Xiude Fan, Bin Zhu, Masoud Nouri-Vaskeh, Chunguo Jiang, Xiaokai Feng, Kyle Poulsen, Behzad Baradaran, Jiansong Fang, Erfan Ahmadi Ade, Akbar Sharifi and 5 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Virology journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xiude Fan *Department of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an, 710061, Shaanxi Province, People's Republic of China.
Bin Zhu *Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Masoud Nouri-Vaskeh *Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Chunguo Jiang *Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.
Xiaokai Feng *Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.
Kyle PoulsenDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Behzad BaradaranImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Jiansong FangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Erfan Ahmadi AdeImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Akbar SharifiTuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Zhigang ZhaoDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Qunying HanDepartment of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an, 710061, Shaanxi Province, People's Republic of China.
Yong ZhangDepartment of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. mailzhangyong@126.com.
Liming ZhangDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China. zhangliming@bjcyh.com.
Zhengwen LiuDepartment of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, No. 277 Yanta West Road, Xi'an, 710061, Shaanxi Province, People's Republic of China. liuzhengwen113@xjtu.edu.cn.ORCID 0000-0002-3965-4947

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRisk scores are needed to predict the risk of death in severe coronavirus disease 2019 (COVID-19) patients in the context of rapid disease progression.

methodsUsing data from China (training dataset, n = 96), prediction models were developed by logistic regression and then risk scores were established. Leave-one-out cross validation was used for internal validation and data from Iran (test dataset, n = 43) was used for external validation.

resultsA NSL model (area under the curve (AUC) 0.932) and a NL model (AUC 0.903) were developed based on neutrophil percentage and lactate dehydrogenase with and without oxygen saturation (SaO

conclusionsThese scores may be used to predict the risk of death in severe COVID-19 patients and the NL score could be used in regions where patients' SaO

Indexed as

Hospital MortalityModels, TheoreticalAgedChinaCOVID-19Disease ProgressionFemaleHumansIranL-Lactate DehydrogenaseMaleMiddle AgedNeutrophilsOxygenPrognosisRetrospective StudiesL-Lactate DehydrogenaseOxygenHospital mortalityPredictionSARS-CoV-2Severe COVID-19

Identifiers

PMID33789703
PMCPMC8011050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.